COMMUNIQUÉS West-GlobeNewswire

Ibogaine Software Serves as a Memoir to a Family Owned and Operated Business
10/05/2024
Ibogaine Research Center Works to Perfect New Software to Continue The Legacy of David Dardashti MIAMI, May 09, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a family run business, has worked for the past 10 [...]
Corza Medical nommée « Meilleure société à l’échelle mondiale dans le domaine des technologies médicales » lors de la 8e édition du programme annuel des MedTech Breakthrough Awards
10/05/2024
Le prestigieux programme international de remise de prix organisé chaque année récompense les produits et entreprises qui se sont démarqués sur le plan de la santé numérique et des technologies médicales WESTWOOD, Mass [...]
Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results
10/05/2024
WEST LAFAYETTE, Ind., May 09, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development [...]
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
10/05/2024
PLEASANTON, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that four independent scientific abstracts accepted for the [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2024 Financial Results on May 15, 2024
10/05/2024
FREDERICK, Md., May 09, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report [...]
PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
09/05/2024
30 month median overall survival (OS); median OS independent of patient CPS score ORR 34% (CPS≥1); 48% (CPS≥20) Phase 3 registrational trial planned to initiate in 2024 PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- [...]
VitalHub Corp. Reports First Quarter 2024 Financial Results
09/05/2024
ARR up 21% YoY to $47.8 million Total Revenue up 21% to $15.3 million EBITDA up 56% YoY to $3.1 million TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX:VHI) (OTCQX:VHIBF) [...]
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
09/05/2024
IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients [...]
Nova Leap Health Corp. Posts Q1 2024 Results
09/05/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 09, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Quipt Home Medical Corp. Announces Filing of Final Base Shelf Prospectus
09/05/2024
CINCINNATI, Ohio, May 09, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “ Company ”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, has filed [...]
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
09/05/2024
HIGH POINT, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an adjunctive therapy to insulin for the treatment of [...]
23andMe to Report Q4 and Full Year FY2024 Financial Results
09/05/2024
SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and [...]
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
09/05/2024
NEW HAVEN, Conn., May 09, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) today announced that two posters, including updated clinical trial data, for vepdegestrant will be presented at the 2024 European Society [...]
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
09/05/2024
Presentations highlight data supporting FILSPARI ® (sparsentan) as a foundational therapy over historical RASi standard of care and in newly diagnosed patients with IgAN SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- [...]
Theratechnologies Reports on its Annual Meeting of Shareholders
09/05/2024
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of [...]
Theratechnologies rend compte de son assemblée annuelle des actionnaires
09/05/2024
MONTRÉAL, 09 mai 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur le développement et la commercialisation de [...]
BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024
09/05/2024
MISSISSAUGA, Ontario, May 09, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2024 on Thursday, May 16, [...]
DBV Technologies to Participate in Upcoming Investor Conferences
09/05/2024
Montrouge, France, May 9, 2024 DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical [...]
Participation de DBV Technologies aux conférences investisseurs en mai
09/05/2024
Montrouge, France, le 9 mai Participation de DBV Technologies aux conférences investisseurs en mai DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), une société biopharmaceutique au [...]

Pages